# Novel plasmid curing mediated restoration of antimicrobial sensitivity by Nigella sativa extract against multidrug resistant Staphylococcus aureus

**Authors:** Adel Attia M. Ahmad, Ashraf M. O. Abdelwahab, Esraa Fawzy, Tarek Khamis, Mohamed Abdelmoneim, Marwa I. Abd El-Hamid

PMC · DOI: 10.1038/s41598-025-33667-3 · Scientific Reports · 2026-01-18

## TL;DR

This study shows that Nigella sativa extract can eliminate antibiotic resistance plasmids in Staphylococcus aureus, offering a new way to combat drug-resistant infections.

## Contribution

The first study to demonstrate plasmid-curing effects of Nigella sativa extract against MDR Staphylococcus aureus.

## Key findings

- NSO and TQ showed plasmid-curing effects comparable to SDS in MDR S. aureus.
- Combining NSO/TQ with antimicrobials or SDS improved plasmid elimination efficiency.
- NSO constituents showed strong binding to enzymes involved in cell wall biosynthesis.

## Abstract

Plasmid-mediated antimicrobial resistance is a major contributor to infections associated with high morbidity and mortality. Given the urgent demand for effective and safe elimination of plasmids from multidrug-resistant (MDR), this study is the first to examine the potential of Nigella sativa essential oil (NSO) and thymoquinone (TQ) in eliminating antimicrobial resistance plasmid from Staphylococcus aureus. Plasmid profiles of resistant variants derived from the original MDR strains following exposure to sublethal concentrations of NSO and TQ were analyzed and compared with those of the untreated parent strains using agar gel electrophoresis. Computational analyses were performed to evaluate the interactions between eleven phytoconstituents of Nigella sativa constituents and cytidylyltransferase (CTP) and glutamine amidotransferase (Gat-D) enzymes, which are involved in cell wall biosynthesis. NSO and TQ exhibited plasmid- curing and MDR reversal effects comparable to SDS. Remarkably, their combination with antimicrobials or SDS resulted in superior plasmid elimination efficiency. The eleven NSO constituents demonstrated moderate to strong binding affinities with CTP and Gat-D enzymes, thereby impairing their catalytic function by obstructing substrate interaction. The plasmid curing property offers a novel therapeutic strategy for combating antibiotic resistance by eliminating resistance genes from infectious S. aureus.

The online version contains supplementary material available at 10.1038/s41598-025-33667-3.

## Linked entities

- **Proteins:** GAT1_2.1 (Class I glutamine amidotransferase-like superfamily protein), gatD (galactitol-1-phosphate dehydrogenase)
- **Chemicals:** thymoquinone (PubChem CID 10281), NSO (PubChem CID 168474081)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Species:** Staphylococcus aureus (species) [taxon 1280]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12820097/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12820097/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12820097/full.md

---
Source: https://tomesphere.com/paper/PMC12820097